Exclusive: Trump admin policy shutting US disease researchers out of WHO virus response talks

Key Points:

• Key US infectious disease officials at the National Institute of Allergy and Infectious Diseases (NIAID) have been barred by the Trump administration from direct communication with the World Health Organization (WHO), limiting their participation in global outbreak discussions.
• The communication restrictions, initially imposed during a hantavirus outbreak, were slightly eased amid an escalating Ebola epidemic in the Democratic Republic of Congo, allowing limited virtual attendance in WHO meetings but only in a listening role with follow-ups routed through the Department of Health and Human Services (HHS).
• The US is experiencing an unprecedented leadership vacuum in national health agencies, with critical positions such as the CDC director, surgeon general, and FDA commissioner either vacant or recently vacated, complicating coordinated responses to public health emergencies.
• The restrictions and leadership gaps stem from broader Trump-era policies including the US withdrawal from WHO and cuts to global health funding, which experts say have weakened early warning and response systems for outbreaks like Ebola.
• Despite these challenges, HHS and CDC officials assert ongoing coordination with WHO and other partners to manage outbreaks, including deploying experts to affected regions and implementing health screenings at US airports for travelers from Ebola-affected areas.